SEARCH

SEARCH BY CITATION

References

  • 1
    American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864874.
  • 2
    Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 2001; 32: 17181728.
  • 3
    Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 2000; 111: 10931102.
  • 4
    Ruokonen E, Nousianen T, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 1999; 18: 283285.
  • 5
    Giamarellou H. Infections in febrile neutropenia. In: CunhaBA, ed. Infectious diseases in critical care medicine. New York: Marcel Dekker, 1998; 563598.
  • 6
    Zahorec R. Definition for septic syndrome should be re-evaluated. Intensive Care Med 2000; 26: 1870.
  • 7
    Christofilopoulou S, Charvalos E, Petrikkos G. Could procalcitonin be a predictive marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med 2002; 13: 493495.
  • 8
    Chirouze C, Schuhmacher H, Rabaud C et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002; 35: 156161.
  • 9
    Hambach L, Eder M, Dammann E et al. Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica 2002; 87: 643651.
  • 10
    Kallio R, Surcel HM, Bloigu A, Syrjala H. C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 2000; 36: 889894.
  • 11
    Engel A, Steinbach G, Kern P, Kern W. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999; 31: 185189.
  • 12
    Sudhoff T, Giagounidis A, Karthaus M. Serum and plasma parameters in clinical evaluation of neutropenic fever. Antibiot Chemother 2000; 50: 1019.
  • 13
    Giamarellos-Bourboulis EJ, Mega A, Grecka P et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002; 28: 13511356.
  • 14
    Barnes C, Ignjatovic V, Newall F et al. Change in serum procalcitonin (delta PCT) predicts the clinical outcome of children admitted with febrile neutropenia. Br J Haematol 2002; 118: 11971198.